Table 2:
Demographic and clinical features of 85 patients with laboratory-proved autoimmune encephalitis, stratified by antibody group
All (n = 85) | Group 1 (n = 18) | Group 2 (n = 67) | P Value | |
---|---|---|---|---|
Age (median) (IQR) | 36 (24–62) | 49.5 (29–64) | 32 (22–61) | .11 |
Male sex | 25/85 (29%) | 4/18 (22%) | 21/67 (31%) | .45 |
CSF leukocytosis | 57/85 (67%) | 11/18 (61%) | 46/67 (69%) | .69 |
CSF elevated protein | 33/85 (39%) | 11/18 (61%) | 22/67 (33%) | .06 |
Diagnosis of malignancy | 15/85 (18%) | 6/18 (33%) | 9/67 (13%) | .05 |
Diagnosis of teratoma/hamartoma | 10/85 (12%) | 2/18 (11%) | 8/67 (12%) | .95 |
Note:—IQR indicates interquartile range.